| |
| |
 "Thank you for an excellent conference. This year's program was the best so far. The panels were all great and the audience was very engaged. I think current economic conditions coupled with the changing FDA and political landscape made this a very timely conference. You can count on continued support from PwC."
Ralph Weinberger, Partner, PricewaterhouseCoopers LLP |
|
 |
| |
"Congratulations on a very successful conference, which is highly informative and useful for networking."
Richard Kramlich, Managing General Partner, New Enterprise Associates |
|
|
| |
"I found the IBF conference extremely useful because it thoroughly covered the topic in a single venue within a compact time frame. The presenters captured a wide range of perspectives on the subject from service provider to user, all with an in-depth base of knowledge and experience. Overall, the forum clearly accomplished its goal of helping companies understand the complete soup-to-nuts components of company financing."
Bruce R. Wright, Chief Executive Officer, Spectrian Corporation |
|
|
| |
"The conference has the ideal mix of value added VCs and experienced executives. It is the key event for keeping on top of this critical region."
Dr. Andrew Jay, Medical Solutions Fund, Siemens Venture Capital, Inc. |
|
|
| |
"This is the one chance I have to take the temperature of what is happening at similar firms--all in one place. This conference alone is very valuable to me. I usually get some takeaways around some techniques/tactics that we haven't yet implemented, and I meet a lot of folks who are useful contacts in the future."
Brendan Walsh, Director, Philips Corporate Venturing |
|
|
| |
"The program was one of the most interesting I have attended and brought together all the right players."
Mark Tiernan, Chief Executive Officer, Aegis Group, Inc. |
|
|
| |
"IBF is a collaborative group, superb at delivering a high-quality conference that attracted investors and entrepreneurs from across the world. IBF was a great partner in pulling together the content for a first-rate meeting, and IBF single-handedly executed a flawless event. Their staff was always available and keen to the high-touch nature of customer service associated with executive meetings."
Baiju Shah, President, BioEnterprise |
|
|
| |
"Congratulations on another great venture conference."
Standish M. Fleming, Partner, Forward Ventures |
|
|
| |
"Great Conference! Lots of good information + opportunity to share ideas with my peers. Well organized + worthwhile!"
Bonnie Caudle, Investment Representative, Edward Jones |
|
|
| |
"This conference will give you the opportunity to hear market intelligence on the dynamics shaping today's private-equity market."
Russell W. Steenberg, Managing Director, Private Equity, Asset Management Group, Merrill Lynch & Co. |
|
|
| |
"I am pleased to share with you that we accomplished more than we could ever have imagined through the conference. Our attendance and participation directly contributed to our establishing a partnership with INTRACORP for a national service program."
Robert Gelb, Vice President and General Manager, QTC Management, Inc. |
|
|
| |
"The IBF Venture Capital Investing Conference is a 'must attend' event and the most important forum of its kind."
Gary J. Morgenthaler, General Partner, Morgenthaler Ventures |
|
|
| |
"International Business Forum (IBF) has some of the longest-lived and respected conferences in the industry."
Jesse Reyes, Bear Stearns Asset Management, Managing Director |
|
|
| |
"This IBF conference is great because it covers all the business elements important to the venture capital industry, both from a fund-raising and management firms perspective for the VCs themselves and for the content that forms the leading edge of the next big investment wave."
Austin Long, Managing Director, Alignment Capital (Former Co-Chair, Institutional Limited Partners Association) |
|
|
| |
"IBF Conferences are a great place to network with old and new associates and a reality check on the various segments of our industry."
John B. Mumford, Co-Founder and General Partner, Crosspoint Venture Partners |
|
|
| |
"Congratulations on such a successful Biotech Investing event! We were very impressed with the turnout and caliber of speakers and attendees."
Erin Larkin, Deloitte & Touche |
|
|
| |
"The IBF Biotech Investing Conference was well attended by the mix of people who help make this industry work...scientist entrepreneurs, management, investors and consultants. It provided me a chance to accomplish a lot in one place."
Brook Byers, Partner, Kleiner Perkins Caufield & Byers |
|
|
| |
"IBF produces very professional conferences, and the best in the biotech sector. It was a fantastic program in November."
Cynthia Robbins-Roth, Ph.D., BioVenture Consultants |
|
|
| |
"Excellent conference. The best privately run conference of its kind--huge turnout and great people at the highest levels of the industry."
Ron Cohen, M.D., President and CEO, Acorda Therapeutics, Inc. |
|
|
| |
"The IBF Nanotech conference is valuable because of the corporates that attend and all that can be accomplished at one event."
Steve Jurvetson, Managing Director, Draper Fisher Jurvetson |
|
|
| |
"IBF's conferences provide great insight into both the investors' and companies' perspectives. It was a valuable experience."
Richard Pace, Principal, Cumberland Development Corp |
|
|
| |
"In order to leverage a competitive advantage one must be competitive. This conference established the criteria and relationships to do both."
Raymond F. Vennare Co-founder and CEO, Thermal Therapeutic Systems, Inc |
|
|
| |
"I continue to be impressed with the talent and sincere support I receive from IBF. IBF is the single most important reason why I would participate in any event they are involved with in the future."
Paul Murdoch, Deputy General Manager, GammaStar Medical Group Ltd |
|
|
|
|
|
